Form 4: Pluri Director Alexandre Weinstein Receives RSU Grant

Pluri Inc. director and 10% owner Alexandre Weinstein was granted 519 restricted stock units as part of the company's equity compensation plan.

Summary

• Alexandre Weinstein, a director and 10% owner of Pluri Inc., was granted 519 restricted stock units (RSUs).
• The RSUs were approved on December 4, 2025, under the Company's 2019 Equity Compensation Plan.
• These RSUs will vest equally on a monthly basis over three months following the grant date.
• Following this transaction, Mr. Weinstein directly owns 10,769 shares of common stock.
• He also indirectly beneficially owns 1,933,415 shares through Chutzpah Holdings Limited (100% owned) and 452,702 shares through Plantae Bioscience Ltd. (77% owned).
• The total beneficial ownership for Mr. Weinstein is 2,396,886 shares.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates continued alignment of a key director's interests with the company's performance through equity compensation, which is a standard and generally healthy practice. It's not highly impactful but is a positive signal for governance.

Positives

• Granting of restricted stock units to a director aligns management's interests with those of shareholders.
• The equity compensation plan helps retain key personnel.

Negatives

• The RSU grant, once vested, will result in a minor increase in outstanding shares, potentially leading to slight dilution for existing shareholders.

Risks

• No specific risks related to the company's operations or financial health are mentioned in this Form 4 filing, as it primarily reports an insider transaction.

Future Outlook

This filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the vesting schedule of the granted RSUs.

Industry Context

This RSU grant is a standard practice in corporate compensation, aligning the interests of a director with the long-term performance of the company. It reflects a common method for retaining and incentivizing key personnel within the biotechnology or pharmaceutical industry, where long-term value creation is paramount.

Comparison to Industry Standards

• Equity compensation, such as RSU grants, is a widely adopted practice across various industries, including biotechnology and pharmaceuticals, to incentivize directors and executives.
• While the specific number of units (519) is small in absolute terms, its significance depends on the company's share price and the overall compensation package.
• Without details on comparable grants from peers like BioNTech, Moderna, or other similar-sized biotech firms, a direct quantitative comparison is not feasible from this filing alone.
• However, the structure of vesting over three months is a common short-to-medium term incentive mechanism.

Corporate Governance

Related Party Transactions

• The filing details Alexandre Weinstein's indirect beneficial ownership through Chutzpah Holdings Limited (100% owned by Mr. Weinstein) and Plantae Bioscience Ltd. (77% owned by Mr. Weinstein), which are related entities for beneficial ownership reporting purposes.

Stakeholder Impact

• Shareholders: Minor potential dilution from the vesting of RSUs, but also improved alignment of a key director's interests with shareholder value.
• Management: The RSU grant serves as an incentive for the director, aligning their compensation with company performance.

Next Steps

• The granted RSUs will vest equally on a monthly basis over three months following the grant date of December 4, 2025.

Key Dates

Recommendation

This Form 4 filing reports a routine equity compensation grant to an existing director and 10% owner. While it aligns management interests with shareholders, the transaction size (519 RSUs) is relatively small and does not provide new material information that would significantly alter the investment thesis for Pluri Inc. Therefore, a 'hold' recommendation is appropriate, as this event alone is unlikely to drive significant price movement or warrant a change in investment strategy.

Keywords

Pluri Inc., PLUR, Alexandre Weinstein, Restricted Stock Units, RSU, Equity Compensation, Insider Transaction, Form 4, Beneficial Ownership, Director, 10% Owner